Hypertension Management Devices – Market Insights – Global

The global market for hypertension management devices consists of devices that represent a novel form of treatment for patients with uncontrolled hypertension. Given the unmet clinical need for effective hypertension management therapies for this patient group, the market is expected to undergo enormous growth once the first product enters the market due to the emergence of strong clinical data and the premium price of these products.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for hypertension management devices in the US, Europe (France, Germany, Italy, Spain, and the UK), and Japan across a 10-year period.

There are enormous market opportunities for hypertension management devices.

How many procedures will be performed by the end of the forecast period?

How will pricing and reimbursement impact the hypertension management device market?

Disappointing data from SYMPLICITY HTN-3, limited physician experience with renal denervation procedures, and competition from anti-hypertensive medications represent barriers to the adoption of renal denervation devices.

What is the biggest barrier to adoption?

How do barriers to adoption vary by country?

There are currently no commercial sales of hypertension management devices in the geographies covered.

When will the commercial sales start in earnest?

How quickly will the device-based treatment be adopted?

The hypertension management device market is largely dependent on clinical trials.

What clinical trials are being conducted for hypertension management devices?

What are the initial results of the trials being performed?

What impact will the results of these trials have on the hypertension management device market?

Table of contents